Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Duke University
With
Centers for Disease Control and Prevention
Kaiser Permanente
Columbia University
Children's Hospital Medical Center, Cincinnati
Age
5–15
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
1. Children ≥ 5 years to \< 16 years of age
2. Receiving first dose or a booster dose of a U.S authorized or approved and recommended COVID-19 vaccine per standard of care
3. Parent/legal authorized representative (LAR) willing to provide written informed consent per local IRB requirements
4. Participant willing to provide assent per local IRB requirements
5. Intention of being available for entire study period and complete all relevant study procedures, including follow-up phone calls
6. English or Spanish literate.
You may not be if
1. Current or planned participation in any clinical trial with an investigational product during the study period.\*
* Per protocol, co-enrollment in observational or behavioral intervention studies are permitted at any time. An investigational product or behavioral intervention permitted at any time. An investigational product may be permitted for therapy of an illness condition that occurs during the study period (e.g., COVID-19 illness)
2. Any condition, which, in the opinion of the investigators, may pose a health risk to the subject or interfere with the evaluation of the study objectives.
3. Anyone who is a relative of any research study personnel or is an employee supervised by study staff.
Clareo Health | Safety of Pediatric COVID-19 Vaccination
